Tissue inhibitor of metalloproteinase 3 inhibits growth of lung cancer tumours in nude mice Source: Eur Respir J 2004; 24: Suppl. 48, 704s Year: 2004
Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 199s Year: 2003
Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006
Splenectomy inhibits tumor development and metastases in murine lung cancer models Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
How to prevent and treat brain metastasis in small cell lung carcinoma Source: International Congress 2015 – How to treat brain metastases Year: 2015
Distinct angiogenic and non-angiogenic growth patterns of lung metastases (LM) from renal cell carcinoma (RCC) Source: Eur Respir J 2003; 22: Suppl. 45, 362s Year: 2003
Bevacizumab (Avastin®) aerosol therapy (AT) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasion Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011
Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004
SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor growth and lung metastasis formation probably through the reduction of tumor angiogenesis Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Effect of VEGF antisense oligonucleotides combined with low molecular weight heparin on the growth and metastasis of mice Lewis lung cancer Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007
Influence of overexpression of coagulantic and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice Source: Eur Respir J 2002; 20: Suppl. 38, 186s Year: 2002
Tumor-related angiogenesis: role in tumour growth and metastasis formation Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005
IGF1R facilitates implantation and progression of lung metastasis acting in the tumor microenvironment Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021
How to treat brain metastasis in patients with non-small cell lung carcinoma (NSCLC) and EGFR mutations Source: International Congress 2015 – How to treat brain metastases Year: 2015
Proteinase inhibition regulates the anti-tumor activity of PAI-1 towards lung and prostate cancer cells Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018
D104N poluymorphism in endostatin, an angiogenesis inhibitor, in lung cancer susceptibility Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006